Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites

doi:10.3748/wjg.v20.i9.2374

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6394)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

439

WORD

304

HTML

3512

Tables (1-5)

121

Sum=4376

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1146

Download

872

Sum=2018

Mar 7, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 7, 2014; 20(9): 2374-2382
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2374

Table 1 Characteristics of the 88 patients studied

Primary liver disease	ETOH	NASH	HCV	Cardiac/miscellaneous	Total
Patients
Ascites (+)	21	0	8	12	41
Ascites (–)	13	11	23	0	47
Age (yr)					54 ± 11
Ascites (+)	50 ± 1	58 ± 5	54 ± 10	55 ± 11
Ascites (–)	48 ± 5	56 ± 8	53 ± 9	56 ± 12
Gender (M/F)					66/22
Ascites (+)	11/9	N/A	14/9	9/8
Ascites (–)	8/3	3/8	4/4	N/A
MELD score					9.6 ± 3.5
Ascites (+)	9.6 ± 2.1	9.3 ± 1.6	10.3 ± 5.0	8.6 ± 2.5
Ascites (–)	9.4 ± 2.2	9.2 ± 2.0	10.0 ± 4.6	8.6 ± 3.1
CTP score					5.6 ± 1.2
Ascites (+)	5.8 ± 1.5	5.3 ± 0.6	5.6 ± 1.5	5.4 ± 0.8
Ascites (–)	5.6 ± 2.0	5.3 ± 0.8	5.6 ± 1.2	5.3 ± 1.2

Data given as mean ± SE. ETOH: Alcohol; NASH: Non-alcoholic steatohepatitis; HCV: Hepatitis C virus; MELD: Model for End-stage Liver Disease; CTP: Childs-Turcotte-Pugh.

Table 2 Biochemical data of the 88 patients

Parameter	Ascitic Group 1(n = 41)	Non-ascitic Group 2(n = 47)	P value
Hemoglobin (g/dL)	10.8 ± 0.4	10.4 ± 1.7	NS
WBC (cells × 10³/μL)	8.3 ± 1.3	6.7 ± 2.8	NS
Platelets (cells × 10³/μL)	132 ± 13	157 ± 66	NS
Prothrombin time (s)	20.5 ± 1.2	17.7 ± 1.1	< 0.05
INR	1.8 ± 0.1	1.5 ± 0.1	< 0.05
BUN (mg/dL)	13.3 ± 7.2	21 ± 4	NS
Creatinine (mg/dL)	1.0 ± 0.7	0.9 ± 0.2	NS
Total bilirubin (mg/dL)	5.9 ± 1.0	4.7 ± 1.9	NS
AST (IU/L)	110 ± 40	98 ± 15	NS
ALT (IU/L)	66 ± 8	210 ± 111	< 0.05
Albumin (g/dL)	2.2 ± 0.1	2.6 ± 0.1	< 0.05
Ascitic fluid WBC (cells × 10³/μL)	417.7 ± 172.5	N/A	N/A
Ascitic fluid PMN (cells × 10³/μL)	196.9 ± 144.2	N/A	N/A
Ascitic fluid albumin (g/dL)	0.90 ± 0.14	N/A	N/A
Ascitic fluid culture	All negative	N/A	N/A

Data given as mean ± SE. INR: International normalized ratio; BUN: Blood urea nitrogen; AST: Aspartate transaminase; ALT: Alanine transaminase; PMN: Polymorphonuclear cells; NS: Non-significant; WBC: White blood cells.

Table 3 Serum and ascitic fluid levels of inflammatory markers in the 88 patients studied

	Ascites Group 1			Non-ascitic Group 2	Control		P value
	Serum	Ascitic fluid	P value	Serum	NPP	P value	Group 1 (serum) vs Group 2	Group 1 (serum) vs NPP
IL-1A (ng/mL)	0.21 ± 0.08	0.21 ± 0.04	NS	0.17 ± 0.07	0.09 ± 0.01	NS	NS	< 0.05
IL-1B (ng/mL)	6.15 ± 2.83	3.10 ± 0.48	NS	3.56 ± 1.11	2.38 ± 0.62	NS	NS	< 0.05
IL-2 (ng/mL)	5.61 ± 3.49	1.31 ± 0.35	< 0.05	0.96 ± 0.01	1.01 ± 0.40	NS	< 0.05	< 0.05
IL-4 (ng/mL)	2.51 ± 0.79	9.48 ± 1.21	< 0.05	1.25 ± 0.07	1.21 ± 0.39	NS	< 0.05	< 0.05
IL-6 (ng/mL)	94.43 ± 29.58	1240.5 ± 365.64	< 0.05	7.27 ± 1.93	0.64 ± 0.16	< 0.05	< 0.05	< 0.05
IL-8 (ng/mL)	111.83 ± 37.01	335.08 ± 60.0	< 0.05	50.19 ± 18.84	2.22 ± 0.79	< 0.05	< 0.05	< 0.05
IL-10 (ng/mL)	1.47 ± 0.31	57.15 ± 22.32	< 0.05	0.95 ± 0.23	0.62 ± 0.08	< 0.05	NS	< 0.05
MCP-1 (ng/mL)	141.23 ± 23.39	456.35 ± 42.03	< 0.05	200.69 ± 18.19	57.11 ± 12.59	< 0.05	< 0.05	< 0.05
TNF-α (ng/mL)	5.26 ± 1.18	26.32 ± 7.13	< 0.05	9.89 ± 3.54	1.61 ± 0.80	< 0.05	NS	< 0.05
IFNγ (ng/mL)	1.08 ± 0.38	1.61 ± 0.41	NS	0.51 ± 0.04	0.47 ± 0.34	NS	< 0.05	NS
VEGF (ng/mL)	38.31 ± 18.73	234.82 ± 103.11		55.94 ± 11.37	7.14 ± 4.06		NS	< 0.05
EGF (ng/mL)	72.42 ± 14.95	1.78 ± 0.36		45.70 ± 7.38	3.12 ± 0.99		< 0.05	< 0.05

Data given as mean ± SE. IL: Interleukin; MCP: Monocyte chemotactic protein; TNF: Tumor necrosis factor alpha; IFN: Interferon gamma; VEGF: Vascular endothelial growth factor; EGF: Epidermal growth factor; NPP: Normal plasma panel; NS: Non-significant.

Table 4 Serum and ascitic procalcitonin levels segregated by liver disease

	Serum	Ascites	P value
EtOH (ng/mL)	0.38 ± 0.22	0.22 ± 0.13	NS
HCV (ng/mL)	0.44 ± 0.27	0.13 ± 0.12	NS
Cardiac/miscellaneous (ng/mL)	0.95 ± 0.74	0.77 ± 0.07	NS
P value	NS	< 0.05^a

^aP < 0.05 cardiac/misc vs non-cardiac diseases only. Data given as mean ± SE. EtOH: Alcohol; HCV: Hepatitis C virus; NS: Not significant.

Table 5 The serum-ascitic fluid (P-A) gradient for Group 1

Serum-ascitic fluid gradient	Value
IL-1A (ng/mL)	-0.0008 ± 0.097
IL-2 (ng/mL)	4.30 ± 3.53
IL-4 (ng/mL)	-6.96 ± 1.48
IL-6 (ng/mL)	-1146.11 ± 362.15
IL-8 (ng/mL)	-223.24 ± 58.54
IL-10 (ng/mL)	-55.68 ± 22.18
MCP-1 (ng/mL)	-315.13 ± 39.24
TNF-α (ng/mL)	-21.06 ± 7.33
IFNγ (ng/mL)	-0.52 ± 0.48
VEGF (ng/mL)	196.52 ± 105.60
EGF (ng/mL)	70.64 ± 14.74
PCT (ng/mL)	-0.134 ± 0.12

Data given as mean ± SE. IL: Interleukin; MCP: Monocyte chemotactic protein; TNF: Tumor necrosis factor α; IFN: Interferon gamma; VEGF: Vascular endothelial growth factor; EGF: Epidermal growth factor; PCT: Procalcitonin.

Citation: Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, Ramadori G, Fareed J, Thiel DHV. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014; 20(9): 2374-2382
URL: https://www.wjgnet.com/1007-9327/full/v20/i9/2374.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i9.2374